- Current report filing (8-K)
05 Août 2010 - 10:52PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
August 5,
2010
BIOVAIL CORPORATION
(Exact
name of registrant as specified in its charter)
Canada
|
|
001-14956
|
|
Not Applicable
|
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
incorporation)
|
|
|
|
Identification
Number)
|
7150 Mississauga Road
Mississauga, Ontario
Canada
|
|
L5N 8M5
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrants telephone number, including area code:
(905) 286-3000
(Former
name or former address, if changed since last report.)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
ITEM 2.02
RESULTS
OF OPERATIONS AND FINANCIAL CONDITION
The
following information is furnished pursuant to Item 2.02, Results of
Operations and Financial Condition.
On
August 5, 2010, Biovail Corporation (the
Company
) issued a press
release setting forth its financial results for its second quarter ended June 30,
2010. A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K. The Company does not intend for this Item
2.02 or Exhibit 99.1 to be deemed filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or to be incorporated by
reference into filings under the Securities Act of 1933, as amended.
ITEM 9.01
FINANCIAL
STATEMENTS AND EXHIBITS
(d)
Exhibit
99.1
Press release
of Biovail Corporation, issued August 5, 2010, and furnished pursuant to
Item 2.02, Results of Operations and Financial Condition.
2
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOVAIL
CORPORATION,
|
|
|
|
by
|
|
|
|
/s/
JENNIFER TINDALE
|
|
|
Name:
|
Jennifer
Tindale
|
|
|
Title:
|
Vice
President, Associate General Counsel and Corporate Secretary
|
|
|
|
|
|
Date: August 5, 2010
3
EXHIBIT INDEX
Exhibit
|
|
|
Number
|
|
Description
|
|
|
|
99.1
|
|
Press release of Biovail
Corporation, issued August 5, 2010, and furnished pursuant to Item 2.02,
Results of Operations and Financial Condition.
|
4
Biovail (NYSE:BVF)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
Biovail (NYSE:BVF)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025